CLARAVIS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Claravis, and when can generic versions of Claravis launch?
Claravis is a drug marketed by Teva Pharms Usa and is included in two NDAs.
The generic ingredient in CLARAVIS is isotretinoin. There is one drug master file entry for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the isotretinoin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Claravis
A generic version of CLARAVIS was approved as isotretinoin by AMNEAL PHARMS NY on September 29th, 2017.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CLARAVIS?
- What are the global sales for CLARAVIS?
- What is Average Wholesale Price for CLARAVIS?
Summary for CLARAVIS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Clinical Trials: | 22 |
| Patent Applications: | 7,488 |
| Drug Prices: | Drug price information for CLARAVIS |
| Drug Sales Revenues: | Drug sales revenues for CLARAVIS |
| DailyMed Link: | CLARAVIS at DailyMed |
Recent Clinical Trials for CLARAVIS
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Children's Oncology Group | Phase 2 |
| National Cancer Institute (NCI) | N/A |
| Children's Oncology Group | N/A |
Pharmacology for CLARAVIS
| Drug Class | Retinoid |
US Patents and Regulatory Information for CLARAVIS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharms Usa | CLARAVIS | isotretinoin | CAPSULE;ORAL | 076356-001 | Apr 11, 2003 | AB1 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Teva Pharms Usa | CLARAVIS | isotretinoin | CAPSULE;ORAL | 076135-001 | Apr 11, 2003 | AB1 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Teva Pharms Usa | CLARAVIS | isotretinoin | CAPSULE;ORAL | 076135-002 | Apr 11, 2003 | AB1 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Teva Pharms Usa | CLARAVIS | isotretinoin | CAPSULE;ORAL | 076135-003 | May 11, 2006 | AB1 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
